NOS3 and endothelial dysfunction: In the vascular endothelium, ROS activates the renin–angiotensin system [20] and reduces nitric oxide (NO) bioavailability by promoting NO inactivation and uncoupling of endothelial nitric oxide synthase (eNOS), resulting in impaired vasodilation and endothelial dysfunction [21].